Versant Venture Management, LLC Contineum Therapeutics, Inc. Transaction History
Versant Venture Management, LLC
- $56.3 Million
- Q2 2025
Number of Shares
542,628
Previous 918,163
40.9%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%